Together, these findings suggest that rosacea and AD share convergent transcriptomic signatures, particularly NF-κB/IL-17/TNF-driven inflammation and vascular remodelling, while pointing to melatonin as a potential modulator. The gene discussed is NFKB1; the disease is rosacea.